ATE476666T1 - Verfahren zur identifizierung von glykoformspezifischen antikörpern - Google Patents

Verfahren zur identifizierung von glykoformspezifischen antikörpern

Info

Publication number
ATE476666T1
ATE476666T1 AT05701355T AT05701355T ATE476666T1 AT E476666 T1 ATE476666 T1 AT E476666T1 AT 05701355 T AT05701355 T AT 05701355T AT 05701355 T AT05701355 T AT 05701355T AT E476666 T1 ATE476666 T1 AT E476666T1
Authority
AT
Austria
Prior art keywords
glycoform
glycoprotein
state
determined
specific antibodies
Prior art date
Application number
AT05701355T
Other languages
English (en)
Inventor
Catherine Ronin
Sandrine Donadio
Original Assignee
Centre Nat Rech Scient
Univ Provence Aix Marseille 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Provence Aix Marseille 1 filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE476666T1 publication Critical patent/ATE476666T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05701355T 2004-02-04 2005-02-04 Verfahren zur identifizierung von glykoformspezifischen antikörpern ATE476666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290290 2004-02-04
PCT/EP2005/001160 WO2005076013A2 (en) 2004-02-04 2005-02-04 Process for screening glycoform-specific antibodies

Publications (1)

Publication Number Publication Date
ATE476666T1 true ATE476666T1 (de) 2010-08-15

Family

ID=34833783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05701355T ATE476666T1 (de) 2004-02-04 2005-02-04 Verfahren zur identifizierung von glykoformspezifischen antikörpern

Country Status (8)

Country Link
US (1) US8431355B2 (de)
EP (1) EP1711834B1 (de)
AT (1) ATE476666T1 (de)
CA (1) CA2554968C (de)
DE (1) DE602005022675D1 (de)
DK (1) DK1711834T3 (de)
ES (1) ES2350298T3 (de)
WO (1) WO2005076013A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1971361B1 (de) 2005-12-23 2014-06-04 James D. Kelly Verbesserte schilddrüsen-stimulierende hormon-rezeptor-polypeptid-agonist-glykoformen zur behandlung des metabolischen syndroms
US20070218503A1 (en) * 2006-02-13 2007-09-20 Mitra Robi D Methods of polypeptide identification, and compositions therefor
US7879799B2 (en) 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN103619358B (zh) 2011-03-31 2017-02-15 辉凌公司 药物制剂
US20150252108A1 (en) * 2012-09-26 2015-09-10 Momenta Pharmaceuticals, Inc. Glycoprotein preparations
WO2014191240A1 (en) * 2013-05-29 2014-12-04 F. Hoffmann-La Roche Ag Quantitative control of sialylation
EP3017057B1 (de) * 2013-07-05 2019-10-02 F.Hoffmann-La Roche Ag Verfahren zur mono- und bi-sialylierung von glykoproteinen unter verwendung von n-terminal verkürzten mutanten der beta-galaktosid alpha-2,6-sialyltransferase
EP2824176A1 (de) 2013-07-11 2015-01-14 Siamed'xpress Verfahren zur Herstellung von sialylierten therapeutischen Proteinen
EP3037527A1 (de) * 2014-12-22 2016-06-29 F. Hoffmann-La Roche AG Sialyltransferase ohne CMP-abhängige Sialidaseaktivität
EP3237608B1 (de) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-abhängige sialidaseaktivität
CN113960232B (zh) * 2021-10-28 2024-02-20 苏州大学 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976876A (en) * 1995-12-11 1999-11-02 The Trustees Of Columbia University In The City Of New York Antibodies specific for hLH β core fragment
WO1999039202A1 (en) * 1998-02-03 1999-08-05 The Trustees Of Columbia University In The City Of New York DETERMINATION OF THE AMOUNT OF hLHβ CORE FRAGMENT IN A SAMPLE FROM A SUBJECT AND USES THEREOF
US6528269B1 (en) 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
EP1143250A3 (de) * 2000-04-03 2004-11-17 Inverness Medical Switzerland GmbH Testverfahren und Vorrichtungen für Analytisoformen

Also Published As

Publication number Publication date
EP1711834A2 (de) 2006-10-18
EP1711834B1 (de) 2010-08-04
WO2005076013A3 (en) 2005-12-08
ES2350298T3 (es) 2011-01-20
CA2554968C (en) 2012-03-27
DK1711834T3 (da) 2010-11-29
DE602005022675D1 (de) 2010-09-16
WO2005076013B1 (en) 2007-03-08
US8431355B2 (en) 2013-04-30
WO2005076013A2 (en) 2005-08-18
US20080199892A1 (en) 2008-08-21
CA2554968A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
ATE476666T1 (de) Verfahren zur identifizierung von glykoformspezifischen antikörpern
NZ598770A (en) Monoclonal antibodies
NZ700473A (en) Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
NL300919I2 (nl) Brodalumab
ATE504599T1 (de) Zur aktivierung von rezeptoren fähige fusionspolypeptide
AR068566A1 (es) Proteinas fijadoras de antigeno de factor de crecimiento del tipo factor de crecimiento epidermico fijador de heparina
WO2007001459A3 (en) Compositions and methods for modulating lymphocyte activity
EP2386577A3 (de) Auf Tumoren zielgerichtete monoklonale Antikörper zu FZD10 und Verwendungen davon
WO2003078600A3 (en) Human monoclonal antibodies to influenza m2 protein and methods of making and using same
TW200626614A (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
WO2003062943A3 (en) Method for analyzing data to identify network motifs
DE69626683D1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
WO2008110593A3 (de) Verfahren und marker zur diagnose von nierenerkrankungen
DE60316758D1 (de) System zur Synchronisierung von Befehlen, sowie ein Verfahren, ein Steuerungsgerät und ein Zielgerät für dasselbe System
EP1412388A4 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
ATE524561T1 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
WO2004046314A3 (en) Methods for detecting asymmetric dimethylarginine in a biological sample
ATE425896T1 (de) Benutzeradaptives system zur automatischen kontrolle von fahrzeugen
EP3959704A4 (de) Verfahren zur verwaltung einer flotte von hochfliegenden langstreckenflugzeugen
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
DE602006010934D1 (de) Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika
DE60330779D1 (de) Für alkalische a-galactosidasen codierende polynukleotidsequenzen und verfahren zur verwendung davon
DE10343265A1 (de) Verfahren zur automatischen Ableitung von Instandhaltungsempfehlungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties